Asset sale Announced Sponsor buyer

Veristat acquisition of Certara Regulatory and Medical Writing business

US$135m consideration

Announced 22 Apr 2026

Advisers

Certara Regulatory and Medical Writing business

Target

Financial adviser
Legal adviser

Veristat

Acquirer

Financial adviser
Legal adviser
Target
Certara Regulatory and Medical Writing business
Acquirer
Veristat
Sponsor
Windrose Health Investors
Seller
Certara
Target based in
United States
Buyer based in
United States
Seller based in
United States
Sector
Pharma Services
Tags
Pharma Services, Life Sciences

In the league tables

Similar deals

All pharma services deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.